Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2025-12-24 @ 5:43 PM
NCT ID: NCT00369668
Eligibility Criteria: Inclusion Criteria: * an ability to complete 10º of wrist or finger extension from a 60 - 65 º flexed position * score less than a 56 on the UE subscale of the Fugl-Meyer Assessment * an ability to voluntarily activate slight movements in the wrist and fingers so that the EMG activity reaches a minimal level on the microprocessor for electrical stimulation to be activated * unilateral, first stroke of ischemic or hemorrhagic origin in the carotid artery distribution * free of major post stroke complications * able to attend therapy 2 days/week or 4 days/week for 2 weeks * score at least a 16 on the Mini Mental Status Examination * able to discriminate sharp from dull and light touch using traditional sensation tests. Exclusion Criteria: * hemiparetic arm is insensate * motor impairments from stroke on opposite side of body * pre-existing neurological disorders such as Parkinson's disease, Multiple Sclerosis, or dementia * Legal blindness or severe visual impairment; 5) Life expectancy less than one year * Severe arthritis or orthopedic problems that limit passive ranges of motion of upper extremity (passive finger extension \< 40º; passive wrist extension \< 40º; passive elbow extension \<40º; shoulder flexion/abduction \< 80º) * History of sustained alcoholism or drug abuse in the last six months * Has pacemaker or other implanted device * pregnant
Healthy Volunteers: False
Sex: ALL
Minimum Age: 44 Years
Maximum Age: 86 Years
Study: NCT00369668
Study Brief:
Protocol Section: NCT00369668